首页> 外文期刊>European Journal of Pharmacology: An International Journal >The new radioligand [3H]-L 748,337 differentially labels human and rat β3-adrenoceptors
【24h】

The new radioligand [3H]-L 748,337 differentially labels human and rat β3-adrenoceptors

机译:新的放射性配体[3H] -L 748,337差异标记人和大鼠β3-肾上腺素受体

获取原文
获取原文并翻译 | 示例
           

摘要

As no suitable radioligand exists for the detection of β3- adrenoceptors, we have explored the radioligand binding properties of a tritiated version of the selective β3-adrenoceptor antagonist L 748,337. Kinetic and equilibrium saturation and competition binding experiments were performed with [3H]-L 748,337 on membrane fractions of HEK and CHO cells stably transfected with human and rat β-adrenoceptor subtypes. Based on both association/dissociation kinetic and equilibrium saturation binding studies in transfected HEK cells, [3H]-L 748,337 exhibited an affinity of approximately 2 nM for human β3-adrenoceptors. Competition studies with agonists and subtype-selective antagonists validated its binding to β3-adrenoceptors. In CHO cells transfected with human β3-adrenoceptors similar saturable high-affinity of [ 3H]-L 748,337 was observed. While some isoprenaline-sensitive [ 3H]-L 748,337 binding was also observed in CHO cells transfected with human β1- or β2-adrenoceptors, this was not saturable in a similar concentration range and/or not sensitive to the antagonists propranolol and SR 59,230, indicating that it did not primarily involve β-adrenoceptors. In CHO cells transfected with rat β3-adrenoceptors [3H]-L 748,337 exhibited a considerably lower affinity than with the human subtype (12-95 nM). Low affinity for the rat β3-adrenoceptor was also found with unlabelled L 748,337 in rat bladder strip relaxation experiments. We conclude that L 748,337 apparently has lower affinity for the rat than the human β3- adrenoceptors and that [3H]-L 748,337 can bind to a low-affinity site distinct from the orthosteric pocket of β-adrenoceptors. Nevertheless, [3H]-L 748,337 appears to be the most promising radioligand for the selective labelling of human β3-adrenoceptors reported to date.
机译:由于没有合适的放射性配体用于检测β3-肾上腺素受体,我们探讨了选择性β3-肾上腺素敏感剂L 748,337的氚化版本的放射性配体结合特性。在HEK和CHO细胞膜级分的[3H] -L 748,337进行动力学和平衡饱和度和竞争结合实验,并稳定地用人和大鼠β-肾上腺素受体亚型转染。基于转染的HEK细胞中的关联/解离动力学和平衡饱和结合研究,[3H] -L 748,337对人β3-肾上腺素受体表示约2nm的亲和力。用激动剂和亚型选择性拮抗剂的竞争研究验证了其与β3-肾上腺素受体的结合。在用人β3-肾上腺素物转染的CHO细胞中,观察到相似的可饱现高亲和力,观察到748,337。虽然在用人β1-或β2-肾上腺素受体转染的CHO细胞中,也观察到一些异戊二醇敏感性[3H] -L 748,337结合,但在类似的浓度范围内并不饱和,而或对拮抗剂普萘洛尔和SR 59,230的浓度不可饱和,表明它没有主要涉及β-肾上腺素受体。在用大鼠转染的CHO细胞中,β3-肾上腺素受体器[3H] -L 748,337表现出比与人亚型(12-95nm)相当较低的亲和力。在大鼠膀胱带弛豫实验中,还发现对大鼠β3-肾上腺素受体的低亲和力。在大鼠膀胱带松弛实验中,未标记的L 748,337也发现。我们得出结论,L 748,337显然对大鼠具有比人β3-肾上腺素受体的亲和力较低,并且[3H] -L 748,337可以与β-肾上腺素受体的骨髓内袋不同的低亲和位点。然而,[3H] -L 748,337似乎是迄今为止报告的人β3-肾上腺素受体的选择性标记最有前途的放射性配体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号